Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases

Wei Xu, Jing Ping Lu, Qizhuang Ye

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Natural-product-derived bengamides possess potent antiproliferative activity and target human methionine aminopeptidases (MetAPs) for their cellular effects. Several derivatives were designed, synthesized, and evaluated as MetAP inhibitors. Here, we present four new X-ray structures of human MetAP1 in complex with the inhibitors. Together with the previous structures of bengamide derivatives with human MetAP2 and tubercular MtMetAP1c, analysis of the interactions of these inhibitors at the active site provides structural basis for further modification of these bengamide inhibitors for improved potency and selectivity as anticancer and antibacterial therapeutics.

Original languageEnglish
Pages (from-to)8021-8027
Number of pages7
JournalJournal of Medicinal Chemistry
Volume55
Issue number18
DOIs
StatePublished - Sep 27 2012

Fingerprint

Aminopeptidases
Methionine
Biological Products
Human Activities
Catalytic Domain
X-Rays
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases. / Xu, Wei; Lu, Jing Ping; Ye, Qizhuang.

In: Journal of Medicinal Chemistry, Vol. 55, No. 18, 27.09.2012, p. 8021-8027.

Research output: Contribution to journalArticle

@article{a32fd9ba526d449da130e843612b6c36,
title = "Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases",
abstract = "Natural-product-derived bengamides possess potent antiproliferative activity and target human methionine aminopeptidases (MetAPs) for their cellular effects. Several derivatives were designed, synthesized, and evaluated as MetAP inhibitors. Here, we present four new X-ray structures of human MetAP1 in complex with the inhibitors. Together with the previous structures of bengamide derivatives with human MetAP2 and tubercular MtMetAP1c, analysis of the interactions of these inhibitors at the active site provides structural basis for further modification of these bengamide inhibitors for improved potency and selectivity as anticancer and antibacterial therapeutics.",
author = "Wei Xu and Lu, {Jing Ping} and Qizhuang Ye",
year = "2012",
month = "9",
day = "27",
doi = "10.1021/jm3008695",
language = "English",
volume = "55",
pages = "8021--8027",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "18",

}

TY - JOUR

T1 - Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases

AU - Xu, Wei

AU - Lu, Jing Ping

AU - Ye, Qizhuang

PY - 2012/9/27

Y1 - 2012/9/27

N2 - Natural-product-derived bengamides possess potent antiproliferative activity and target human methionine aminopeptidases (MetAPs) for their cellular effects. Several derivatives were designed, synthesized, and evaluated as MetAP inhibitors. Here, we present four new X-ray structures of human MetAP1 in complex with the inhibitors. Together with the previous structures of bengamide derivatives with human MetAP2 and tubercular MtMetAP1c, analysis of the interactions of these inhibitors at the active site provides structural basis for further modification of these bengamide inhibitors for improved potency and selectivity as anticancer and antibacterial therapeutics.

AB - Natural-product-derived bengamides possess potent antiproliferative activity and target human methionine aminopeptidases (MetAPs) for their cellular effects. Several derivatives were designed, synthesized, and evaluated as MetAP inhibitors. Here, we present four new X-ray structures of human MetAP1 in complex with the inhibitors. Together with the previous structures of bengamide derivatives with human MetAP2 and tubercular MtMetAP1c, analysis of the interactions of these inhibitors at the active site provides structural basis for further modification of these bengamide inhibitors for improved potency and selectivity as anticancer and antibacterial therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84866863979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866863979&partnerID=8YFLogxK

U2 - 10.1021/jm3008695

DO - 10.1021/jm3008695

M3 - Article

C2 - 22913487

AN - SCOPUS:84866863979

VL - 55

SP - 8021

EP - 8027

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 18

ER -